menu
    • menu

    Company profile for Servier Canada

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    Arlanda is your partner for the Brazil market.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Servier possesses a unique cultural heritage as a privately owned, French research based ethical pharmaceutical Company. We produce innovative drugs for doctors and their patients around the world. At the same time, driven by medical needs of humankind and advances in science and technology, we strive to meet the demands of the future.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Servier CanadaCanada Flag
    Country
    Country
    Canada
    Address
    Address
    235, boul. Armand-Frappier Laval (Quebec) H7V 4A7
    Telephone
    Telephone
    450-978-9700
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.servier.ca/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/servier-canada
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Cosmoprof WW Bologna

    Cosmoprof WW Bologna

    Not Confirmed

    envelop Contact Supplier

    Cosmoprof WW Bologna

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Once aiming to double oncology pipeline, Servier's US branch touts
    Once aiming to double oncology pipeline, Servier's US branch touts

    12 Jan 2021

    // Conner Mitchell ENDPTS

    https://endpts.com/once-aiming-to-double-oncology-pipeline-serviers-us-branch-touts-rapid-pace-in-building-its-foothold-in-the-space/

    Conner Mitchell ENDPTS
    12 Jan 2021
    Share Share
    Servier to acquire Agios Pharmaceuticals’ oncology assets for $2bn
    Servier to acquire Agios Pharmaceuticals’ oncology assets for $2bn

    22 Dec 2020

    // PRESS RELEASE

    https://servier.com/en/communique/servier-to-acquire-agios-pharmaceuticals-oncology-business-pr/

    PRESS RELEASE
    22 Dec 2020
    Share Share
    Servier to acquire Agios Pharmaceuticals’ oncology assets for $2bn
    Servier to acquire Agios Pharmaceuticals’ oncology assets for $2bn

    22 Dec 2020

    // SERVIER

    https://servier.com/en/communique/servier-to-acquire-agios-pharmaceuticals-oncology-business-pr/

    SERVIER
    22 Dec 2020
    Share Share
    Servier and MBC BioLabs Announce Winner of the 2020 Servier Golden Ticket
    Servier and MBC BioLabs Announce Winner of the 2020 Servier Golden Ticket

    24 Sep 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/servier-and-mbc-biolabs-announce-winner-of-the-2020-servier-golden-ticket-301137141.html

    PRNEWSWIRE
    24 Sep 2020
    Share Share
    Oncodesign & Servier Reach a Key 1st Milestone in Their Partnership on LRRK2
    Oncodesign & Servier Reach a Key 1st Milestone in Their Partnership on LRRK2

    17 Feb 2020

    // PRESS RELEASE

    https://servier.com/en/communique/oncodesign-and-servier-reach-a-key-first-milestone/

    PRESS RELEASE
    17 Feb 2020
    Share Share
    LONSURF®trifluridine/tipiracil Receives Marketing Authorization EU for Patient
    LONSURF®trifluridine/tipiracil Receives Marketing Authorization EU for Patient

    05 Sep 2019

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20190905005861/en

    BUSINESSWIRE
    05 Sep 2019
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search